DNA Methylation Status of SOX10 Correlates with Its Downregulation and Oligodendrocyte Dysfunction in Schizophrenia
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Downregulation of oligodendrocyte-related genes, referred to as oligodendrocyte dysfunction, in schizophrenia has been revealed by DNA microarray studies. Because oligodendrocyte-specific transcription factors regulate the differentiation of oligodendrocytes, genes encoding them are prime candidates for oligodendrocyte dysfunction in schizophrenia. We found that the cytosine-guanine dinucleotide (CpG) island of sex-determining region Y-box containing gene 10 (SOX10), an oligodendrocyte-specific transcription factor, tended to be highly methylated in brains of patients with schizophrenia, correlated with reduced expression of SOX10. We also found that DNA methylation status of SOX10 also was associated with other oligodendrocyte gene expressions in schizophrenia. This may be specific to SOX10, because the CpG island of OLIG2, which encodes another oligodendrocyte-specific transcription factor, was rarely methylated in brains, and the methylation status of myelin-associated oligodendrocytic basic protein, which encodes structural protein in oligodendrocytes, did not account for their expressions or other oligodendrocyte gene expressions. Therefore, DNA methylation status of the SOX10 CpG island could be an epigenetic sign of oligodendrocyte dysfunction in schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,914
CpG Islands in vertebrate genomes
Gardiner-Garden, M., & Frommer, M. (1987) · Journal of Molecular Biology · doi:10.1016/0022-2836(87)90689-9 · Cited by 3,353 · cited 1×
“The CpG islands (Gardiner-Garden and Frommer, 1987) of oligodendrocyte genes were obtained through the University of California, Santa Cruz Genome Browser (http://www.”
MethodMethPrimer: designing primers for methylation PCRs
Li, L.-C., & Dahiya, R. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.11.1427 · Cited by 2,729 · cited 1×
“Primer pairs determined using MethPrimer software (Li and Dahiya, 2002) were as follows: SOX10, 5 -TGGGTAAGGTTAAGAAGGAGTAGTAG-3 and 5 -CTACCTAAACCCACACCATAAAAAC-3 ; OLIG2-1, 5 -TTTTAAGTTTTTGTTTTTAGTTGGG-3 and 5 -AATCTCCTCCCTAACTCTTCCTCTAT-3 ; OLIG2-2, 5 -TAGAGGAAGAGTTAG-GGAGGAGATT-3 and 5 -ACCACCACAAAATCAAATTAAAAAA-3…”
Large-scale analysis of the human and mouse transcriptomes
Su, A. I., Cooke, M. P., Ching, K. A., Hakak, Y., Walker, J. R., Wiltshire, T., Orth, A. P., Vega, R. G., Sapinoso, L. M., Moqrich, A., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012025199 · Cited by 1,466 · cited 2×
“A melanoma cell line, A2058, was selected as a SOX10-expressing cell line (Su et al., 2002) using the SOURCE website, (http://source.stanford.edu) (Diehn et al., 2003).”
MethodHakak, Y., Walker, J. R., Li, C., Wong, W. H., Davis, K. L., Buxbaum, J. D., Haroutunian, V., & Fienberg, A. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081071198 · Cited by 1,192 · cited 4×
“…downregulation of a subset of oligodendrocyte-related genes (referred to as oligodendrocyte dysfunction) in prefrontal [Brodmann area (BA) 46 (Hakak et al., 2001; Tkachev et al., 2003) or BA47 (Sugai et al., 2004)] and temporal [BA21 (Aston et al., 2004)] cortices of patients with…”
BackgroundResultInfluentialLu, Q. R., Sun, T., Zhu, Z., Ma, N., Garcia, M., Stiles, C. D., & Rowitch, D. H. (2002) · Cell · doi:10.1016/s0092-8674(02)00678-5 · Cited by 1,073 · cited 1×
“OLIG2 plays a role in the specification of oligodendrocytes and motor neurons (Lu et al., 2002), and MOBP is one of the major protein components of myelin.”
BackgroundOligodendrocyte dysfunction in schizophrenia and bipolar disorder
Tkachev, D., Mimmack, M. L., Ryan, M. M., Wayland, M., Freeman, T., Jones, P. B., Starkey, M., Webster, M. J., Yolken, R. H., & Bahn, S. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14289-4 · Cited by 933 · cited 8×
“…of a subset of oligodendrocyte-related genes (referred to as oligodendrocyte dysfunction) in prefrontal [Brodmann area (BA) 46 (Hakak et al., 2001; Tkachev et al., 2003) or BA47 (Sugai et al., 2004)] and temporal [BA21 (Aston et al., 2004)] cortices of patients with schizophrenia have been…”
BackgroundResultInfluentialSchizophrenia genesis: the origins of madness
(1991) · Choice Reviews Online · doi:10.5860/choice.28-6500 · Cited by 832
White Matter Changes in Schizophrenia: Evidence for Myelin-Related Dysfunction
Davis, K. L., Stewart, D. G., Friedman, J. I., Buchsbaum, M., Harvey, P. D., Hof, P. R., Buxbaum, J., & Haroutunian, V. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.5.443 · Cited by 793 · cited 1×
“Although the results remain inconclusive, magnetic resonance imaging studies suggested some changes in white matter in patients with schizophrenia, and these changes are considered related to the above findings (Davis et al., 2003; Stewart and Davis, 2004).”
Stolt, C. C., Rehberg, S., Ader, M., Lommes, P., Riethmacher, D., Schachner, M., Bartsch, U., & Wegner, M. (2002) · Genes & Development · doi:10.1101/gad.215802 · Cited by 684 · cited 3×
“…a combination of transcription factors such as SOX10 and oligodendrocyte lineage transcription factor 1 (OLIG1) and OLIG2 regulates the differentiation of oligodendrocytes (Kessaris et al., 2001), and that SOX10 is responsible for terminal differentiation of oligodendrocytes (Stolt et al., 2002).”
BackgroundUranova, N. A., Vostrikov, V. M., Orlovskaya, D. D., & Rachmanova, V. I. (2004) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00181-6 · Cited by 659 · cited 1×
“Electron microscopic studies revealed the ultrastructural alteration of oligodendroglias (Uranova et al., 2004).”
BackgroundThe Stanley Foundation brain collection and Neuropathology Consortium
Torrey, E. F., Webster, M., Knable, M., Johnston, N., & Yolken, R. H. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00192-9 · Cited by 533 · cited 2×
“The original data set (Torrey et al., 2000) was composed of 15 control subjects and 15 schizophrenic patients.”
MethodIwamoto, K., Bundo, M., & Kato, T. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi022 · Cited by 495 · cited 1×
“Our analysis of BA10 (Iwamoto et al., 2004) failed to detect oligodendrocyte dysfunction in bipolar disorder and major depression, whereas that of BA46 (Iwamoto et al., 2005) revealed the downregulation of oligodendrocyte genes in both diseases (data not shown).”
BackgroundSelf-citationFlynn, S. W., Lang, D. J., Mackay, A. L., Goghari, V, Vavasour, I. M., Whittall, K. P., Smith, G. N., Arango, V, Mann, J. J., Dwork, A. J., et al. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001337 · Cited by 438 · cited 5×
“Immunohistochemical analysis revealed the downregulation of oligodendrocyte proteins in gray matter (Honer et al., 1999; Flynn et al., 2003) and alteration in number and density of oligodendrocytes in layer III of the cortex in schizophrenia (Hof et al., 2003).”
BackgroundResultInfluentialHof, P. R., Haroutunian, V., Friedrich, V. L., Byne, W., Buitron, C., Perl, D. P., & Davis, K. L. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00237-3 · Cited by 433 · cited 2×
“Immunohistochemical analysis revealed the downregulation of oligodendrocyte proteins in gray matter (Honer et al., 1999; Flynn et al., 2003) and alteration in number and density of oligodendrocytes in layer III of the cortex in schizophrenia (Hof et al., 2003).”
BackgroundMolecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations
Inoue, K., Khajavi, M., Ohyama, T., Hirabayashi, S.-I., Wilson, J., Reggin, J. D., Mancias, P., Butler, I. J., Wilkinson, M. F., Wegner, M., et al. (2004) · Nature Genetics · doi:10.1038/ng1322 · Cited by 429 · cited 3×
“We did not find the putative functional SNPs that change amino acid sequences or cause degradation by the NMD pathway (Inoue et al., 2004).”
BackgroundInfluentialSOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data
Diehn, M. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg014 · Cited by 428 · cited 1×
“A melanoma cell line, A2058, was selected as a SOX10-expressing cell line (Su et al., 2002) using the SOURCE website, (http://source.stanford.edu) (Diehn et al., 2003).”
MethodAston, C., Jiang, L., & Sokolov, B. P. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001565 · Cited by 427 · cited 1×
“Oligodendrocyte dysfunction has also been reported in bipolar disorder (Tkachev et al., 2003) and major depression (Aston et al., 2005).”
Abdolmaleky, H. M., Cheng, K., Russo, A., Smith, C. L., Faraone, S. V., Wilcox, M., Shafa, R., Glatt, S. J., Nguyen, G., Ponte, J. F., et al. (2005) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30140 · Cited by 390 · cited 2×
“To date, DNA methylation of the reelin promoter was suggested to be involved in its downregulation in schizophrenia (Veldic et al., 2004; Abdolmaleky et al., 2005), and site-specific DNA methylation of catechol-O-methyltransferase promoter was proposed to be altered in schizophrenia (Murphy et al.”
BackgroundIwamoto, K., Kakiuchi, C., Bundo, M., Ikeda, K., & Kato, T. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001437 · Cited by 331 · cited 9×
“Primer pairs for GAPDH, ACTB, and CFL1 have been shown previously (Iwamoto et al., 2004).”
BackgroundMethodResultInfluentialSelf-citationVeldic, M., Caruncho, H. J., Liu, W. S., Davis, J., Satta, R., Grayson, D. R., Guidotti, A., & Costa, E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2637013100 · Cited by 300 · cited 2×
“To date, DNA methylation of the reelin promoter was suggested to be involved in its downregulation in schizophrenia (Veldic et al., 2004; Abdolmaleky et al., 2005), and site-specific DNA methylation of catechol-O-methyltransferase promoter was proposed to be altered in schizophrenia (Murphy et al.”
BackgroundMicroarray analysis of postmortem temporal cortex from patients with schizophrenia
Aston, C., Jiang, L., & Sokolov, B. P. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20208 · Cited by 283 · cited 3×
“…a subset of oligodendrocyte-related genes (referred to as oligodendrocyte dysfunction) in prefrontal [Brodmann area (BA) 46 (Hakak et al., 2001; Tkachev et al., 2003) or BA47 (Sugai et al., 2004)] and temporal [BA21 (Aston et al., 2004)] cortices of patients with schizophrenia have been revealed.”
BackgroundResultSynaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness
Honer, W. G., Falkai, P., Chen, C., Arango, V., Mann, J. J., & Dwork, A. J. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00679-4 · Cited by 244 · cited 4×
“Immunohistochemical analysis revealed the downregulation of oligodendrocyte proteins in gray matter (Honer et al., 1999; Flynn et al., 2003) and alteration in number and density of oligodendrocytes in layer III of the cortex in schizophrenia (Hof et al., 2003).”
BackgroundResultInfluentialThe origin of schizophrenia: genetic thesis, epigenetic antithesis, and resolving synthesis
Petronis, A. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.005 · Cited by 225 · cited 1×
“Accumulating evidence suggests that complex mental disorders may be mediated through aberrant epigenetic processes (Costa et al., 2003; Abdolmaleky et al., 2004; Petronis, 2004).”
BackgroundAbdolmaleky, H. M., Smith, C. L., Faraone, S. V., Shafa, R., Stone, W., Glatt, S. J., & Tsuang, M. T. (2004) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20142 · Cited by 216 · cited 1×
“Accumulating evidence suggests that complex mental disorders may be mediated through aberrant epigenetic processes (Costa et al., 2003; Abdolmaleky et al., 2004; Petronis, 2004).”
BackgroundBunney, W. E., Bunney, B. G., Vawter, M. P., Tomita, H., Li, J., Evans, S. J., Choudary, P. V., Myers, R. M., Jones, E. G., Watson, S. J., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.657 · Cited by 132 · cited 1×
“Gene expression analyses using DNA microarray also support the alteration of oligodendrocytes in schizophrenia (Bunney et al., 2003; Mirnics et al., 2004).”
Ventral Neurogenesis and the Neuron-Glial Switch
Kessaris, N., Pringle, N. P., & Richardson, W. D. (2001) · Neuron · doi:10.1016/s0896-6273(01)00430-5 · Cited by 117 · cited 3×
“…a combination of transcription factors such as SOX10 and oligodendrocyte lineage transcription factor 1 (OLIG1) and OLIG2 regulates the differentiation of oligodendrocytes (Kessaris et al., 2001), and that SOX10 is responsible for terminal differentiation of oligodendrocytes (Stolt et al., 2002).”
BackgroundSUGAI, T., KAWAMURA, M., IRITANI, S., ARAKI, K., MAKIFUCHI, T., IMAI, C., NAKAMURA, R., KAKITA, A., TAKAHASHI, H., & NAWA, H. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1316.011 · Cited by 115 · cited 3×
“…a subset of oligodendrocyte-related genes (referred to as oligodendrocyte dysfunction) in prefrontal [Brodmann area (BA) 46 (Hakak et al., 2001; Tkachev et al., 2003) or BA47 (Sugai et al., 2004)] and temporal [BA21 (Aston et al., 2004)] cortices of patients with schizophrenia have been revealed.”
BackgroundMurphy, B. C., O'Reilly, R. L., & Singh, S. M. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30134 · Cited by 102 · cited 2×
“, 2005), and site-specific DNA methylation of catechol-O-methyltransferase promoter was proposed to be altered in schizophrenia (Murphy et al., 2005).”
BackgroundPossible Contributions of Myelin and Oligodendrocyte Dysfunction to Schizophrenia
Stewart, D. G., & Davis, K. L. (2004) · International review of neurobiology · doi:10.1016/s0074-7742(04)59015-3 · Cited by 56 · cited 1×
“Although the results remain inconclusive, magnetic resonance imaging studies suggested some changes in white matter in patients with schizophrenia, and these changes are considered related to the above findings (Davis et al., 2003; Stewart and Davis, 2004).”
ResultCosta, E., Grayson, D. R., & Guidotti, A. (2003) · Molecular Interventions · doi:10.1124/mi.3.4.220 · Cited by 53 · cited 1×
“Accumulating evidence suggests that complex mental disorders may be mediated through aberrant epigenetic processes (Costa et al., 2003; Abdolmaleky et al., 2004; Petronis, 2004).”
BackgroundDNA Microarray Analysis of Postmortem Brain Tissue
Mirnics, K., Levitt, P. R., & Lewis, D. A. (2004) · International review of neurobiology · doi:10.1016/s0074-7742(04)60006-7 · Cited by 28 · cited 1×
“Gene expression analyses using DNA microarray also support the alteration of oligodendrocytes in schizophrenia (Bunney et al., 2003; Mirnics et al., 2004).”
Mitochondrial calcium response in human transformed lymphoblastoid cells
Kato, T., Ishiwata, M., & Nagai, T. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01725-3 · Cited by 18 · cited 1×
“A lymphoblastoid cell line, TC42, was established from the lymphocytes of a 28-year-old Japanese male with no history of neuropsychiatric diseases using standard techniques (Kato et al., 2002).”
MethodSelf-citation
Cited by
Shrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,914
Epigenetic regulation of gene expression in physiological and pathological brain processes
Gräff, J., Kim, D., Dobbin, M. M., & Tsai, L.-H. (2011) · Physiological Reviews · doi:10.1152/physrev.00012.2010 · Cited by 373
Promoter-Wide Hypermethylation of the Ribosomal RNA Gene Promoter in the Suicide Brain
McGowan, P. O., Sasaki, A., Huang, T. C. T., Unterberger, A., Suderman, M., Ernst, C., Meaney, M. J., Turecki, G., & Szyf, M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002085 · Cited by 372
Epigenetic basis of mental illness
Nestler, E. J., Peña, C. J., Kundakovic, M., Mitchell, A., & Akbarian, S. (2016) · The Neuroscientist · doi:10.1177/1073858415608147 · Cited by 342
Genome-wide DNA methylation analysis of human brain tissue from schizophrenia patients
Wockner, L. F., Noble, E. P., Lawford, B. R., Young, R. M., Morris, C. P., Whitehall, V. L. J., & Voisey, J. (2014) · Translational Psychiatry · doi:10.1038/tp.2013.111 · Cited by 310
Metadata
- Authors
- Iwamoto, K., Bundo, M., Yamada, K., Takao, H., Iwayama-Shigeno, Y., Yoshikawa, T., & Kato, T.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2005-06-01
- Volume
- 25
- Issue
- 22
- Pages
- 5376-5381
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W1964850060
- Cited by
- 242
- References
- 33
- FWCI
- 7.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.